Antidepressant Discontinuation Syndrome | AAFP Advertisement search close brand logo
CHRISTOPHER H. WARNER, MAJ, MC, USA, WILLIAM BOBO, LCDR, MC, USN …

OBJECTIVE: To provide clinicians with a critical evaluation of citalopram, a selective
serotonin reuptake inhibitor (SSRI) that has been available in Canada since March 1999 …

Objective Antidepressants are at best 50–55% effective. Non‐compliance and the
antidepressant discontinuation syndrome (ADS) are causally related yet poorly appreciated …

Objective—To determine whether short-term amitriptyline administration would be
efficacious in the treatment of acute, nonobstructive, idiopathic lower urinary tract disease in …

Depressive disorders require long-term treatment with antidepressants, psychotherapy, or
both. The goal of antidepressant therapy is complete remission of symptoms and return to …

Antidepressant drugs are currently one of the most prescribed medications. In addition to
treatment resistance and side effects of antidepressants, their clinical use is further …

This case report describes a 46-year-old woman with long-standing episodic severe
depression (ICD-10 code F33) who discontinued venlafaxine over a 4-week taper after …

Depressive illness is now recognised as a major health problem. As many patients do not
need indefinite treatment, clinicians need to be aware of the symptoms associated with the …

PURPOSE/OBJECTIVES: To describe evolving psychopharmacologic options for managing
depression related to cancer. DATA SOURCES: Literature review and case study. DATA …

The use of psychopharmacologic agents in children is complicated by several factors. One
important neurobiologic consideration is the relationship of the effect of the medication to …